Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae
NCT01167777 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2296
Last updated 2015-11-26
Summary
Multicenter clinical study to test a new qualitative in vitro nucleic acid amplification assay based on kPCR technology. The assay is intended for the diagnosis of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC).
Conditions
- Chlamydia
- Gonorrhea
Sponsors & Collaborators
-
Siemens Healthcare Diagnostics Inc
lead INDUSTRY
Principal Investigators
-
NORMAND DESPRES, PhD · Siemens Healthcare Diagnostics
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- United States
Study Locations
More Related Trials
-
Rapid Diagnostic Assay for Gonorrhea and Chlamydia
NCT05564299 ·Status: COMPLETED ·Phase: NA
-
Incubation Time and Test of Cure of Chlamydia Trachomatis
NCT01448876 ·Status: COMPLETED
-
Aztreonam for Pharyngeal Gonorrhea
NCT03867734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Detection of Chlamydia (CT) and Gonorrhea (NG)
NCT02055742 ·Status: COMPLETED
-
Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT
NCT02870101 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the ID NOW™ CT/NG Test
NCT06395675 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System
NCT01358799 ·Status: WITHDRAWN
-
Home Screening for Chlamydia Surveillance
NCT00177437 ·Status: COMPLETED ·Phase: PHASE3
-
A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test
NCT00682851 ·Status: COMPLETED
-
A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
NCT02092259 ·Status: UNKNOWN
-
A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients
NCT03037957 ·Status: COMPLETED
-
A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections
NCT06369220 ·Status: COMPLETED ·Phase: NA
-
A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples
NCT00827697 ·Status: COMPLETED
-
Development of a Self-collection Device for Cervical Cancer Screening
NCT05669911 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing
NCT01849653 ·Status: COMPLETED
-
Clinical Performance of the Checkable Medical At-Home Strep A Test
NCT05107362 ·Status: COMPLETED
-
Evaluation of the Atlas Genetics io® CTNG System
NCT03071510 ·Status: COMPLETED
-
Improving Maternal and Child Health Through Point-of-care STI Testing
NCT07290439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
NCT00115388 ·Status: COMPLETED ·Phase: NA
-
Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM]
NCT01291264 ·Status: TERMINATED
-
Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
NCT02795975 ·Status: TERMINATED
-
Point of Care Rapid STI Test Optimization and Validation Extension
NCT06566677 ·Status: COMPLETED
-
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
NCT01728103 ·Status: TERMINATED
-
Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing
NCT00978848 ·Status: COMPLETED
-
Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT
NCT05831098 ·Status: COMPLETED ·Phase: NA